Literature DB >> 7999312

The myeloneuropathies of Jamaica.

O St Clair Morgan1.   

Abstract

This article summarizes the present state of knowledge of TSP/HAM as it is seen in Jamaica. It reviews the historical and clinical aspects of the disease, and shows how the discovery of HTLV-I has generated research in several countries and contributed to a better understanding of the disease. It highlights the need for continued collaboration between basic scientists and clinical neurologists in order that the dilemmas relating to therapy and pathogenicity may be successfully addressed.

Entities:  

Mesh:

Year:  1994        PMID: 7999312     DOI: 10.1007/BF02780666

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  37 in total

1.  CLINICAL AND PATHOLOGICAL OBSERVATIONS ON JAMAICAN NEUROPATHY; A REPORT ON 206 CASES.

Authors:  R D MONTGOMERY; E K CRUICKSHANK; W B ROBERTSON; W H MCMENEMEY
Journal:  Brain       Date:  1964-09       Impact factor: 13.501

2.  A neuropathic syndrome of uncertain origin; review of 100 cases.

Authors:  E K CRUICKSHANK
Journal:  West Indian Med J       Date:  1956-09       Impact factor: 0.171

3.  Spontaneous lymphocyte proliferation in symptom-free HTLV-I positive Jamaicans.

Authors:  A Krämer; S Jacobson; J F Reuben; E L Murphy; S Z Wiktor; B Cranston; J P Figueroa; B Hanchard; D McFarlin; W A Blattner
Journal:  Lancet       Date:  1989-10-14       Impact factor: 79.321

4.  Necropsy findings in HTLV-I associated myelopathy.

Authors:  S Akizuki; O Nakazato; Y Higuchi; K Tanabe; M Setoguchi; S Yoshida; Y Miyazaki; S Yamamoto; S Sudou; K Sannomiya
Journal:  Lancet       Date:  1987-01-17       Impact factor: 79.321

5.  Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP).

Authors:  Y Iwasaki
Journal:  J Neurol Sci       Date:  1990-04       Impact factor: 3.181

6.  Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy.

Authors:  J Kira; Y Itoyama; Y Koyanagi; J Tateishi; M Kishikawa; S Akizuki; I Kobayashi; N Toki; K Sueishi; H Sato
Journal:  Ann Neurol       Date:  1992-01       Impact factor: 10.422

7.  Serologic evidence of human immunodeficiency virus infection of the central nervous system in African patients with acquired immunodeficiency syndrome.

Authors:  R Kaiser; R Dörries; J ter Meulen; J J Kidenya; M Pöllath; K Fleischer; V ter Meulen
Journal:  Eur Neurol       Date:  1990       Impact factor: 1.710

8.  Human T-lymphotropic virus type I antibodies in the serum of patients with tropical spastic paraparesis in the Seychelles.

Authors:  G C Román; B S Schoenberg; D L Madden; J L Sever; J Hugon; A Ludolph; P S Spencer
Journal:  Arch Neurol       Date:  1987-06

Review 9.  Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I).

Authors:  A Gessain; O Gout
Journal:  Ann Intern Med       Date:  1992-12-01       Impact factor: 25.391

10.  Increases in helper inducer T cells and activated T cells in HTLV-I-associated myelopathy.

Authors:  Y Itoyama; J Kira; N Fujii; I Goto; N Yamamoto
Journal:  Ann Neurol       Date:  1989-08       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.